XML 56 R45.htm IDEA: XBRL DOCUMENT v3.23.1
Income per Share Attributable to Amphastar Pharmaceuticals, Inc. Stockholders (Narrative) (Details) - Employee and Non-Employee Stock Options [Member] - $ / shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Shares 1,403,859 706,740
Antidilutive Securities Excluded from Computation of Earnings Per Share, Exercise Price of Excluded Securities $ 34.96 $ 34.74